Ionis Pharmaceuticals, Inc.
Modulators of APOL1 Expression

Abstract:

The present embodiments provide methods, compounds, and compositions useful for inhibiting APOL1 expression, which may be useful for treating, preventing, or ameliorating a disease associated with APOL1.